10.1 Adrenal Cortex & Medulla Hormones

Adrenal Cortex & Medulla Hormones

The adrenal glands (historically designated the suprarenal glands) are paired, highly vascularized, pyramid-shaped endocrine organs situated directly atop the superior apical poles of each kidney. Retroperitoneal in position, each adrenal gland measures approximately 3 to 5 centimeters in length, 2 to 3 centimeters in width, and weighs roughly 4 to 5 grams in a healthy adult. Each gland is securely enclosed within the renal fascia and enveloped by a protective adipose capsule.

Despite their unified gross appearance under a shared fibrous capsule, each adrenal gland is structurally, functionally, and embryologically composed of two completely separate endocrine organs fused together:

1. Adrenal Cortex: The outer, firm glandular region constituting 80% to 90% of total gland volume. Derived embryologically from mesoderm, the cortex consists of epithelial cords specialized for the de novo synthesis and secretion of lipid-soluble corticosteroid hormones from cholesterol.
2. Adrenal Medulla: The inner, soft, highly vascularized neuroendocrine core constituting the remaining 10% to 20% of total gland volume. Derived embryologically from neural crest ectoderm, the medulla functions as a modified sympathetic autonomic ganglion specialized for the rapid secretion of water-soluble catecholamines.

Adrenal Gland (Suprarenal Gland) Structural Architecture

  Fibrous Connective Tissue Capsule
  ┌──────────────────────────────────────────────────────────────┐
  │ ADRENAL CORTEX (Mesodermal origin; Steroid hormones)          │
  │  ├─ Zona Glomerulosa (~15%) ──> Mineralocorticoids (Aldosterone)│
  │  ├─ Zona Fasciculata (~75%) ──> Glucocorticoids (Cortisol)   │
  │  └─ Zona Reticularis (~10%) ──> Gonadocorticoids (Androgens) │
  ├──────────────────────────────────────────────────────────────┤
  │ ADRENAL MEDULLA (Neural crest ectoderm; Catecholamines)      │
  │  └─ Chromaffin Cells ─────────> Epinephrine & Norepinephrine  │
  └──────────────────────────────────────────────────────────────┘

---

The Adrenal Cortex: Zonal Histology & Corticosteroids

Cells of the adrenal cortex store large quantities of intracellular lipids, particularly cholesterol and fatty acids. From this cholesterol backbone, cortical cells synthesize more than two dozen steroid hormones, collectively known as corticosteroids. Because steroid hormones are lipophilic, they are not packaged into storage vesicles; instead, they are synthesized on demand and diffuse immediately across the plasma membrane into adjacent fenestrated sinusoidal capillaries.

Histologically, the adrenal cortex is partitioned into three concentric morphological zones, arranged from superficial (subcapsular) to deep (adjacent to the medulla). A high-yield clinical mnemonic used by healthcare professionals is GFR (matching the nephrology term Glomerular Filtration Rate) paired with the functional mnemonic "Salt, Sugar, Sex — the deeper you go, the sweeter it gets":

• G = Zona Glomerulosa $\rightarrow$ Salt (Mineralocorticoids: Aldosterone regulates sodium/salt balance)
• F = Zona Fasciculata $\rightarrow$ Sugar (Glucocorticoids: Cortisol elevates blood glucose/sugar)
• R = Zona Reticularis $\rightarrow$ Sex (Gonadocorticoids: Androgens regulate sex steroid precursors)

---

1. Zona Glomerulosa: Mineralocorticoids (Aldosterone)

The zona glomerulosa is the outermost cortical layer, residing immediately deep to the fibrous capsule and comprising approximately 15% of cortical volume.

• Histological Architecture: Secretory cells are arranged in tightly packed, spherical clusters or curved arcades (resembling little balls, or glomeruli) surrounded by rich capillary networks.
• Primary Hormone: Mineralocorticoids, predominantly Aldosterone, which accounts for greater than 95% of all mineralocorticoid activity in the human body.
• Target Tissues & Physiological Mechanisms:
  • Target: Principal cells of the late distal convoluted tubules (DCT) and cortical collecting ducts of the renal nephrons.
  • Mechanism of Action: Aldosterone diffuses across the basolateral membrane of principal cells and binds to intracellular cytoplasmic mineralocorticoid receptors. The hormone-receptor complex translocates into the nucleus, binding to hormone response elements on DNA to upregulate the gene transcription and synthesis of apical Epithelial Sodium Channels (ENaC) and basolateral $Na^+/K^+$ ATPase pumps.
  • Electrolyte & Fluid Effects: Active transport drives the reabsorption of sodium ($Na^+$) from the tubular urine filtrate back into the peritubular capillaries, while simultaneously stimulating the excretion of potassium ($K^+$) (and hydrogen ions, $H^+$, via intercalated cells) into the urine. Because water passively follows sodium down osmotic gradients (in the presence of antidiuretic hormone), aldosterone promotes fluid retention, expanding intravascular blood volume and elevating systemic arterial blood pressure.
• Regulatory Control:
  1. Renin-Angiotensin-Aldosterone System (RAAS): The primary physiological regulator. When renal perfusion pressure falls, sympathetic nerves fire, or sodium delivery to the macula densa drops, juxtaglomerular (JG) cells of the renal afferent arterioles secrete renin. Renin enzymatically converts circulating hepatic angiotensinogen into angiotensin I. As blood passes through vascular beds (predominantly the pulmonary capillary endothelium), Angiotensin-Converting Enzyme (ACE) cleaves angiotensin I into angiotensin II. Angiotensin II binds to cell-surface G-protein coupled receptors on zona glomerulosa cells, stimulating rapid synthesis and exocytosis of aldosterone.
  2. Serum Potassium Concentration: Direct humoral regulation. A minor elevation in extracellular $K^+$ concentration depolarizes zona glomerulosa cell membranes, opening voltage-gated calcium channels; calcium influx directly activates aldosterone synthase. This feedback mechanism prevents fatal cardiac arrhythmias caused by hyperkalemia.
  3. Atrial Natriuretic Peptide (ANP): Potent physiological antagonist. Secreted by cardiac atrial myocytes in response to excessive atrial stretching from high blood volume or pressure, ANP directly inhibits renin release and blocks aldosterone secretion, promoting renal natriuresis (sodium excretion) and diuresis to lower blood pressure.

---

2. Zona Fasciculata: Glucocorticoids (Cortisol)

The zona fasciculata is the intermediate and thickest layer of the adrenal cortex, comprising approximately 75% of total cortical volume.

• Histological Architecture: Composed of long, straight, parallel columns or cords of large, polyhedral cells separated by parallel sinusoidal capillaries. The cytoplasm contains numerous clear lipid droplets, giving these cells a pale, foamy appearance under light microscopy (frequently called spongiocytes).
• Primary Hormone: Glucocorticoids, primarily Cortisol (hydrocortisone), alongside small amounts of corticosterone and cortisone.
• Target Tissues & Physiological Mechanisms:
  • Metabolic Actions ("Glucose-Sparing" & Fuel Mobilization): Cortisol is the premier chronic stress adaptation hormone. It maintains blood glucose to support brain function during fasting, exercise, trauma, or emotional stress:
    • Hepatic Gluconeogenesis: Stimulates liver enzymes to synthesize new glucose molecules from non-carbohydrate substrates, including amino acids, glycerol, and lactate.
    • Protein Catabolism: Stimulates the breakdown of contractile and structural proteins in skeletal muscle, releasing free amino acids into the bloodstream to serve as substrates for hepatic gluconeogenesis.
    • Lipolysis: Stimulates adipose tissue lipases to break down stored triglycerides into free fatty acids and glycerol, mobilizing lipid fuels for peripheral tissues while sparing circulating glucose for the central nervous system.
    • Decreased Peripheral Glucose Uptake: Reduces glucose transporter translocation in skeletal muscle and adipose tissue, generating physiological insulin resistance to ensure adequate glucose delivery to obligate glucose consumers (neurons and erythrocytes).
  • Anti-Inflammatory and Immunosuppressive Actions:
    • Inhibits phospholipase $A_2$ (via induction of lipocortin/annexin A1), preventing the liberation of arachidonic acid from cell membranes and halting the downstream synthesis of inflammatory prostaglandins and leukotrienes.
    • Stabilizes lysosomal membranes, preventing the leakage of tissue-damaging proteolytic enzymes during cellular injury.
    • Decreases capillary permeability, preventing inflammatory exudate formation and tissue edema.
    • Suppresses interleukin synthesis (including IL-1, IL-2, and IL-6) and inhibits the proliferation, migration, and cytokine release of T-lymphocytes, B-lymphocytes, monocytes, and mast cells.
  • Cardiovascular & Permissive Effects: Exerts a critical permissive effect on vascular catecholamines. Cortisol upregulates alpha-1 adrenergic receptors on vascular smooth muscle; without adequate basal cortisol, arterioles become refractory to epinephrine and norepinephrine, leading to profound vasodilation and circulatory collapse.
• Regulatory Control (The HPA Axis):
  • Governed by the Hypothalamic-Pituitary-Adrenal (HPA) axis. The paraventricular nucleus of the hypothalamus secretes Corticotropin-Releasing Hormone (CRH) into the hypophyseal portal system. CRH stimulates anterior pituitary corticotrophs to synthesize pro-opiomelanocortin (POMC) and release Adrenocorticotropic Hormone (ACTH) into systemic blood. ACTH binds to melanocortin-2 receptors on zona fasciculata cells, activating adenylate cyclase and stimulating cortisol synthesis.
  • Negative Feedback: Circulating cortisol feeds back to the hypothalamus and anterior pituitary, inhibiting CRH and ACTH release.
  • Diurnal Circadian Rhythm: Cortisol secretion displays a marked 24-hour diurnal pattern under the control of the hypothalamic suprachiasmatic nucleus. Peak secretion occurs in the early morning shortly before waking (approximately 06:00 to 08:00 AM), preparing the body for daytime activity, and reaches its lowest nadir around midnight. Acute physical or psychological stressors override this circadian rhythm, driving persistent ACTH and cortisol surges.

---

3. Zona Reticularis: Gonadocorticoids (Adrenal Sex Steroids)

The zona reticularis is the innermost cortical layer, located immediately adjacent to the adrenal medulla and comprising approximately 10% of cortical volume.

• Histological Architecture: Consists of small, darkly staining cells arranged in an irregular, branching, net-like meshwork (reticulum) interspersed with wide capillary sinusoids. Cells contain abundant yellow-brown lipofuscin granules (wear-and-tear pigment).
• Primary Hormones: Gonadocorticoids, consisting predominantly of weak androgens: Dehydroepiandrosterone (DHEA), its sulfated ester DHEA-S, and androstenedione.
• Target Tissues & Physiological Mechanisms:
  • Adrenal androgens exhibit minimal intrinsic biological activity. Upon secretion, they circulate to peripheral tissues (such as adipose tissue, skin, hair follicles, and gonads), where intracellular enzymes convert them into potent sex steroids: testosterone in males and females, or estrogens (estradiol) in females.
  • Role in Males: In adult post-pubertal men, the large volume of testosterone produced continuously by testicular Leydig cells vastly overshadows adrenal androgen output, rendering adrenal gonadocorticoid secretion clinically negligible under normal physiological conditions.
  • Role in Females & Children: In prepubertal children, adrenal androgen secretion surges during adrenarche (around ages 6 to 8), contributing to the prepubertal growth spurt and initiating the development of axillary and pubic hair. In adult females, adrenal androgens represent the principal source of circulating androgens, responsible for sustaining normal female libido (sex drive), axillary/pubic hair growth, and serving as the primary source of postmenopausal estrogen conversion following ovarian follicular failure.
• Regulatory Control: Stimulated by anterior pituitary ACTH. Unlike cortisol, adrenal androgens do not exert substantial negative feedback on CRH or ACTH secretion.

---

The Adrenal Medulla: Neuroendocrine Core & Catecholamines

Occupying the central core of each adrenal gland, the adrenal medulla is not a true epithelial endocrine gland; rather, it is functionally and structurally a modified sympathetic ganglion of the autonomic nervous system.

Embryology & Histology

During embryonic development, neural crest ectodermal cells migrate from the neural tube into the developing adrenal primordium. Instead of developing long axonal processes and synaptic terminals like classical sympathetic postganglionic neurons, these cells differentiate into spherical, secretory neuroendocrine cells called chromaffin cells (or pheochromocytes).

• Chromaffin cells receive direct synaptic innervation from myelinated preganglionic sympathetic fibers that descend from the thoracic spinal cord (splanchnic nerves) through the sympathetic chain without synapsing.
• Preganglionic terminals release the neurotransmitter acetylcholine (ACh) onto nicotinic receptors on chromaffin cell membranes. Acetylcholine binding triggers membrane depolarization, opening voltage-gated calcium channels. Calcium influx induces rapid exocytosis of membrane-bound secretory granules directly into medullary capillary sinusoids.

Catecholamine Hormones & Actions

The chromaffin cells synthesize and store catecholamines, derived biosynthetically from the amino acid tyrosine (tyrosine $\rightarrow$ L-DOPA $\rightarrow$ dopamine $\rightarrow$ norepinephrine $\rightarrow$ epinephrine). Medullary secretions consist of:

• Epinephrine (Adrenaline): Comprises approximately 80% of total medullary catecholamine output. Epinephrine acts as a broad agonist at alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors. It is the more potent stimulator of heart rate, myocardial contractility, metabolic glycogenolysis, and bronchodilation (via beta-2 receptors).
• Norepinephrine (Noradrenaline): Comprises approximately 20% of total medullary output. Norepinephrine primarily stimulates alpha-1, alpha-2, and beta-1 receptors, with minimal beta-2 affinity. It exerts profound systemic vasoconstriction, sharply elevating total peripheral resistance and mean arterial blood pressure.

The Acute "Fight-or-Flight" Stress Response

While cortical glucocorticoids mediate sustained, chronic metabolic adaptations to prolonged stress over hours and days, medullary catecholamines mediate the instantaneous, explosive "fight-or-flight" autonomic response within seconds of acute stress or perceived threat:

1. Cardiovascular Acceleration: Beta-1 adrenergic stimulation increases sinoatrial node firing rate (positive chronotropy), atrioventricular node conduction velocity (positive dromotropy), and ventricular myocardial contractility (positive inotropy), drastically boosting cardiac output.
2. Vascular Redistribution: Alpha-1 adrenergic stimulation causes pronounced vasoconstriction in non-essential vascular beds (cutaneous vessels, kidneys, digestive viscera), while beta-2 adrenergic stimulation promotes vasodilation in skeletal muscle arterioles and coronary arteries, shunting oxygenated blood to contracting muscles.
3. Respiratory Facilitation: Beta-2 adrenergic stimulation relaxes bronchial smooth muscle, causing profound bronchodilation and reducing airway resistance to maximize pulmonary alveolar ventilation.
4. Immediate Metabolic Fuel Mobilization: Epinephrine stimulates hepatic and skeletal muscle glycogenolysis (rapid enzymatic cleavage of stored glycogen into glucose) and activates adipose tissue lipolysis, flooding the systemic circulation with immediately oxidizable glucose and free fatty acids.
5. Sensory & Visceral Shunting: Epinephrine stimulates pupillary dilation (mydriasis) via radial iris muscle contraction to optimize visual input, while simultaneously inhibiting gastrointestinal peristalsis, secretomotor activity, and bladder wall contraction.

---

Comparison Table: Adrenal Functional Anatomy & Zonal Histology

---

Clinical Pathophysiology of the Adrenal Glands

Clinical disorders of the adrenal glands typically present as either hypersecretory or hyposecretory states, producing characteristic multisystem signs and symptoms heavily emphasized on nursing and health science licensing exams.

1. Cushing's Syndrome vs. Cushing's Disease (Hypercortisolism)

Cushing's syndrome is the clinical constellation resulting from chronic, excessive tissue exposure to glucocorticoids (hypercortisolism):

• Etiology:
  • Iatrogenic Cushing's Syndrome: The single most common clinical cause; results from long-term pharmacological administration of high-dose exogenous corticosteroids (e.g., prednisone, dexamethasone) for autoimmune or inflammatory disorders.
  • Cushing's Disease: Specifically designates hypercortisolism caused by an ACTH-secreting anterior pituitary microadenoma (accounts for ~70% of endogenous cases).
  • Adrenal Cushing's: Primary autonomous cortisol-secreting adrenocortical adenoma or carcinoma (ACTH is suppressed by negative feedback).
  • Ectopic ACTH Syndrome: Non-pituitary neuroendocrine tumor (e.g., small cell lung carcinoma) secreting biological ACTH.
• Clinical Features:
  • Central Adiposity: Characterized by abnormal fat redistribution producing a rounded "moon face", a dorsocervical fat pad ("buffalo hump"), and supraclavicular fullness with paradoxically thin, wasted extremities.
  • Protein Catabolism & Skin Changes: Severe muscle protein breakdown leads to proximal muscle weakness and atrophy. Collagen catabolism causes cutaneous thinning, easy capillary bruising, and prominent wide, violaceous (purple) striae across the abdomen, thighs, and breasts.
  • Metabolic Derangements: Sustained hepatic gluconeogenesis and anti-insulin effects induce hyperglycemia (termed "adrenal diabetes") and secondary polyuria.
  • Skeletal & Vascular Changes: Demineralization of bone matrix leads to severe osteoporosis and pathological fractures. Mineralocorticoid cross-reactivity and catecholamine sensitization produce chronic arterial hypertension.
  • Immune Suppression: Impaired wound healing, high susceptibility to opportunistic infections, and leukocytosis without localized inflammatory signs.

2. Addison's Disease (Primary Adrenocortical Insufficiency)

Addison's disease is a chronic, progressive hyposecretory disorder characterized by the bilateral destruction of all three layers of the adrenal cortex, resulting in combined deficiency of both glucocorticoids and mineralocorticoids.

• Etiology: In developed nations, 80% to 90% of cases stem from autoimmune adrenalitis (autoantibodies directed against 21-hydroxylase enzyme). Globally, infectious destruction via tuberculosis, fungal infections, or bilateral adrenal metastases remain major causes.
• Clinical Features:
  • Cutaneous Hyperpigmentation: Striking, diffuse bronze hyperpigmentation of the skin, especially prominent over sun-exposed areas, palmar creases, pressure points (knuckles, elbows, knees), and mucous membranes (buccal mucosa). Mechanism: The profound deficiency of circulating cortisol eliminates negative feedback at the anterior pituitary and hypothalamus, triggering massive secretion of POMC and ACTH. The POMC prohormone contains the amino acid sequence for melanocyte-stimulating hormone (MSH); excessive circulating ACTH/MSH peptides bind to melanocortin-1 receptors on epidermal melanocytes, stimulating melanin synthesis.
  • Fluid & Electrolyte Derangements: Loss of aldosterone prevents distal nephron sodium reabsorption and potassium excretion, producing severe hyponatremia (low serum $Na^+$), hyperkalemia (elevated serum $K^+$), and mild metabolic acidosis. Uncontrolled urinary sodium wasting pulls water with it, causing chronic dehydration, hypovolemia, and marked orthostatic hypotension.
  • Metabolic Deficits: Cortisol deficiency impairs gluconeogenesis, producing frequent fasting hypoglycemia, profound chronic fatigue, muscle weakness, anorexia, nausea, and progressive weight loss.
  • Addisonian Crisis (Acute Adrenal Crisis): A medical emergency precipitated by acute physiological stress (e.g., infection, trauma, surgery, acute dehydration) or the abrupt cessation of chronic exogenous corticosteroid therapy. Presents with refractory hypovolemic shock, intractable vomiting, abdominal pain, severe hyponatremia, hyperkalemia, vascular collapse, and coma. Requires immediate intravenous resuscitation with isotonic saline, dextrose, and high-dose hydrocortisone.

3. Pheochromocytoma (Adrenal Medullary Hypersecretion)

A pheochromocytoma is a rare, typically benign neuroendocrine tumor arising from the chromaffin cells of the adrenal medulla (or extra-adrenal sympathetic paraganglia) that autonomously synthesizes and hypersecretes massive quantities of catecholamines (epinephrine and norepinephrine).

• The Classic Triad: Paroxysmal (episodic) attacks characterized by:
  1. Severe, pounding headache
  2. Profuse diaphoresis (drenching sweats)
  3. Tachycardia and intense cardiac palpitations
• Hallmark Sign: Severe, often paroxysmal or refractory arterial hypertension. During an attack, patients experience extreme anxiety, tremors, facial pallor, and epigastric pain. Diagnosed by detecting elevated free metanephrines (catecholamine breakdown metabolites) in plasma or 24-hour urine collection.

---

Comparison Table: Cushing's Syndrome vs. Addison's Disease